AVISTA PHARMA Trademark

Trademark Overview

On Thursday, May 26, 2016, a trademark application was filed for AVISTA PHARMA with the United States Patent and Trademark Office. The USPTO has given the AVISTA PHARMA trademark a serial number of 87051023. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 10, 2024. This trademark is owned by Avista Pharma Solutions, Inc.. The AVISTA PHARMA trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Early to late phase drug manufacturing services for others; and manufacturing of drug substances and custom synthesis for new or transferred substances for others
avista pharma

General Information

Serial Number87051023
Word MarkAVISTA PHARMA
Filing DateThursday, May 26, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 10, 2024
Registration Number5314668
Registration DateTuesday, October 24, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2017

Trademark Statements

Goods and ServicesEarly to late phase drug manufacturing services for others; and manufacturing of drug substances and custom synthesis for new or transferred substances for others
NOT AVAILABLE"PHARMA"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 10, 2024
Primary Code040
First Use Anywhere DateMonday, June 29, 2015
First Use In Commerce DateTuesday, June 30, 2015

Trademark Owner History

Party NameAvista Pharma Solutions, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713
Party NameAvista Pharma Solutions, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27713
Party NameAvista Pharma Solutions, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27713

Trademark Events

Event DateEvent Description
Wednesday, September 14, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 30, 2016NEW APPLICATION ENTERED
Friday, June 3, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, September 11, 2016ASSIGNED TO EXAMINER
Wednesday, September 14, 2016NON-FINAL ACTION WRITTEN
Wednesday, September 14, 2016NON-FINAL ACTION E-MAILED
Monday, June 26, 2017EXAMINERS AMENDMENT E-MAILED
Friday, December 2, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 17, 2016ASSIGNED TO LIE
Wednesday, January 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 9, 2017NON-FINAL ACTION WRITTEN
Thursday, February 9, 2017NON-FINAL ACTION E-MAILED
Thursday, February 9, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 26, 2017EXAMINERS AMENDMENT -WRITTEN
Monday, June 26, 2017EXAMINER'S AMENDMENT ENTERED
Monday, June 26, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 8, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 8, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, December 16, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, June 26, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 6, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 11, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 24, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 10, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

pharma avista manufacturing others substances drug transferred custom synthesis services late phase